Michael Rosenbaum

Has grant

Associate Professor/Professor

Columbia University Irving Medical Center
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Rosenbaum is an Associate Professor at Columbia University Medical Center in the United States. His research primarily focuses on weight history, energy expenditure, and obesity in both clinical and developmental contexts. Recent publications examine the physiological mechanisms of weight loss as well as evaluations of health programs targeted at families managing childhood obesity.

Recent Grants

Grant: Close

Functional imaging and eating behavior among FTO genotypes in pre-obese children

Open Date: 2013-09-18

Close Date: 2018-08-31

Grant: Close

Functional imaging and eating behavior among FTO genotypes in pre-obese children

Open Date: 2012-09-24

Close Date: 2013-08-31

Grant: Close

ONTOGENY AND MAINTENANCE OF REGIONAL FAT DISTRIBUTION

Open Date: 1991-05-01

Close Date: 1996-04-30

Articles (4)

Objective The traditional measure of weight suppression (TWS; the difference between an individual's highest past weight at adult height and current weight), has been associated with many psychological, behavioral and biological variables in those with eating disorders. A new measure of weight suppression, called developmental weight suppression (DWS), corrects two major problems in the original measure. Initial research indicates that DWS represents a superior operationalization of the construct weight suppression was originally designed to measure (Lowe [1993, Psychol Bull, 114: 100]). This study is the first to examine the relation between both WS measures and weight history, body composition and a variety of metabolic hormones. Methods Data were collected in 91 women with bulimia nervosa (BN) or BN‐spectrum disorders. Results Both weight suppression indices were related to multiple hormones. However, multiple regression analyses showed that the independent effects of DWS differed from the independent effects of TWS in that only DWS was negatively related to: (1) current z‐BMI, (2) body fat percentage, and (3) insulin, leptin, T3 free, and TSH. This differential pattern also occurred when results were corrected for multiple comparisons. Discussion Findings provide stronger biological support for the construct validity of DWS than TWS and suggest that: (1) from the perspective of individuals with BN, high DWS embodies success at food restriction and weight loss, (2) elevated DWS may trap individuals with BN in a powerful biobehavioral bind, and (3) DWS is the preferred measure of weight suppression in future research on eating disorders. Public Significance Most individuals with bulimia nervosa lose substantial weight in the process of developing their disorder. Such weight suppression is related to many characteristics of those with the eating disorder bulimia nervosa. This study shows why a new measure of weight suppression, based on an individual's growth during development, is more biologically valid than the traditional measure of weight suppression.

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Collaborators (2)

Aviva Sopher

Associate Professor of Pediatrics

-

UNITED STATES
View details

Laurel Mayer

-

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.